Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages en Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

SDG-GoodHealth-Infectious-DE

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.000060215627IMPFSTOFF ZUR MODULATION ZWISCHEN T1 UND T2 IMMUNANTWORTEN
DE 19.07.2007
Int.Class A61K 9/127
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
9Medicinal preparations characterised by special physical form
10Dispersions; Emulsions
127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
Appl.No 60215627 Applicant BIOMIRA INC Inventor BUDZYNSKI A
2.000010158057Use of 3,5-dinitrobenzoate ester, 3,5-dinitrobenzamide or 3,5-dinitrophenyl ketone derivatives for therapy and/or diagnosis of microbial infections, especially tuuberculosis or malaria
DE 12.06.2003
Int.Class A61K 31/24
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
235having an aromatic ring attached to a carboxyl group
24having an amino or nitro group
Appl.No 10158057 Applicant KNOELL HANS FORSCHUNG EV Inventor KAPPES BARBARA

3,5-Dinitrobenzoate ester, 3,5-dinitrobenzamide or 3,5-dinitrophenyl ketone derivatives (I) are claimed for use as medicaments or active agents in the therapy and/or diagnosis of microbial infections in humans or animals. Dinitrobenzene derivatives of formula (I) (including their salts or complexes) are claimed for use as medicaments or active agents in the therapy and/or diagnosis of microbial infections in humans or animals. R<1> = alkyl (preferably 1-3C alkyl, n-butyl or tert. butyl); R<2> = H, halo, 1-3C alkyl, n-butyl or tert. butyl; R<3> = aromatic residue (preferably benzyl or naphthyl, both optionally substituted by one or more of halo, 1-3C alkyl, n-butyl or tert. butyl) or a non-aromatic residue (e.g. n-butyl, tert. butyl or cyclohexyl); R<4> = NH, O or CH2.

3.000069916022Methode zur Verwendung von IL-11 zur Verstärkung der zellvermittelten Immunität zur Behandlung verschiedener viraler und parasitärer Infektionen und Krebs
DE 02.09.2004
Int.Class A61K 38/2
Appl.No 69916022 Applicant INST GENETICS LLC Inventor TREPICCHIO L
4.202024100319Biologisch abbaubare Nanopartikel-Zusammensetzung zur kontrollierten Freisetzung antiviraler Wirkstoffe in der HIV/AIDS-Therapie
DE 21.03.2024
Int.Class A61K 9/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders
Appl.No 202024100319 Applicant Aundhia Chintan Inventor

Eine biologisch abbaubare Nanopartikelzusammensetzung zur kontrollierten Freisetzung antiviraler Arzneimittel in der HIV/AIDS-Therapie, bestehend aus: 50 bis 70 Gew.-% Poly(milch-co-glykolsäure) (PLGA), 20 bis 40 Gew.-% Chitosan und 5 bis 15 Gew.-% eines antiviralen Mittels.

5.000010205864Combination preparations, useful for the treatment of protozoal infections, especially malaria, comprise a lincosamide antibiotic such as clindamycin and a dispiro-tetraoxane compound, e.g. TetA
DE 21.08.2003
Int.Class A61K 31/357
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
357having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
Appl.No 10205864 Applicant JOMAA PHARMAKA GMBH Inventor

Pharmaceutical combination preparations (A), useful for treating parasitic protozoal infections, comprise a lincosamide antibiotic (I) and a dispiro-1,2,4,5-tetraoxane compound (II), for simultaneous, separate or successive administration. Pharmaceutical combination preparations (A), useful for treating parasitic protozoal infections, comprise a lincosamide antibiotic (I) and a tetraoxane compound of formula (II), for simultaneous, separate or successive administration. R1-R24 = H, OH or halo; or 1-26C alkyl, 1-26C alkoxy, 1-26C alkoxyalkyl, 1-26C hydroxyalkyl, aryl, acyl, aralkyl, 2-26C alkenyl, 2-26C alkynyl, cycloalkyl, heterocyclyl or silyl; and i, j, k, l, m, n = 0 or 1; One or more double or triple bonds may be present (in which case two or more of R1-R24 are absent).

6.000010115310Bakteriophagen-Präparation
DE 10.10.2002
Int.Class A61K 39/295
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
295Polyvalent viral antigens; Mixtures of viral and bacterial antigens
Appl.No 10115310 Applicant NODAR A DANIELA Inventor NODAR A DANELIA

The invention relates to a composition comprising bacteriophages and endotoxins and to a medicament that contains such a composition. The invention further relates to the use of said medicament for treating bacterial diseases, fungal infections and/or inflammations. The inventive composition can also be used as cleaning agent or/and disinfectant.

7.000010205863Combination preparations for treating protozoal infections, especially malaria, containing lincosamide antibiotic and endoperoxide antimalarial agent, e.g. clindamycin and artesunate
DE 21.08.2003
Int.Class A61K 31/357
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
357having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
Appl.No 10205863 Applicant JOMAA PHARMAKA GMBH Inventor

Pharmaceutical combination preparations (A) for treating parasitic protozoal infections contain a lincosamide antibiotic (I) and an endoperoxide antimalarial agent (II), for simultaneous, separate or successive administration. Pharmaceutical combination preparations (A) for treating parasitic protozoal infections contain a lincosamide antibiotic (I) and an endoperoxide antimalarial agent of formula (II), for simultaneous, separate or successive administration. R1 - R3, R5 = Q; or R1 + R8 = -O-CR9R10- (with the O bonded at the R1 position); R7 + R4 or R7 + R6 = -CR11R12- CR13R14-CR15R16- or CR11R12-CR13R14-CR15R16-CR17R18- (both with CR11R12 bonded at the R7 positions); R4, R6 (when not linked to R7) = Q; R9, R11 - R18 = Q; R10 = ; or R10 + R1 = -O-CR19R20-CR21R22- (with the O bonded at the R10 position); or R13 + R14 = O; R19 = OZ' or is absent; R20 = Q; or R19 + R20 = O; R21, R22 = Q or one of the two may be absent; Q = H, OH, halo, 1-26C alkyl, 1-26C hydroxyalkyl, aryl, acyl, aralkyl, 2-26C alkenyl, 2-26C alkynyl, cycloalkyl or heterocyclyl (all optionally substituted); Z' = H or OH; or 1-26C alkyl, 1-26C hydroxyalkyl, aryl, acyl, aralkyl, 2-26C alkenyl, 2-26C alkynyl, cycloalkyl, heterocyclyl or amino (all optionally substituted); and n = 0 or 1.

8.WO/2002/076483BACTERIOPHAGE PREPARATION
WO 03.10.2002
Int.Class A61K 38/46
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
46Hydrolases (3)
Appl.No PCT/EP2002/003464 Applicant DANELIA, Nodar, A. Inventor DANELIA, Nodar, A.
The invention relates to a composition comprising bacteriophages and endotoxins and to a medicament that contains such a composition. The invention further relates to the use of said medicament for treating bacterial diseases, fungal infections and/or inflammations. The inventive composition can also be used as cleaning agent or/and disinfectant.
9.000069737956CD8 Tuberkulose Impfstoffe
DE 17.04.2008
Int.Class C07K 14/35
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
195from bacteria
35from Mycobacteriaceae (F)
Appl.No 69737956 Applicant ISIS INNOVATION Inventor LALVANI AJIT
10.000010007771Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE 23.08.2001
Int.Class A61K 39/295
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
295Polyvalent viral antigens; Mixtures of viral and bacterial antigens
Appl.No 10007771 Applicant KLEINE & STEUBE ENTOXIN GMBH Inventor TRENEL ANGELA

The invention relates to immunomodulatory effective microbiological compositions, to methods for the production thereof and to their use. The inventive microbiological immunomodulators are suited for use in active and passive immunization. The inventive compositions are primarily used as homeopathic medicaments in the areas of cardiac and circulator disorders, hypertonia or allergic ailments. The immunomodulatory effective microbiological compositions are comprised of equal parts of antigen and antitoxin suspensions and are potentiated using a potentiating solution.